Published in Clin Breast Cancer on March 24, 2015
A nationwide survey of knowledge of and compliance with cancer pain management guidelines by korean physicians. Cancer Res Treat (2014) 1.51
Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms. Pathol Int (2006) 1.09
Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas. Mod Pathol (2012) 1.00
Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy. J Korean Med Sci (2011) 1.00
The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer (2015) 0.94
New technique for developing a proton range compensator with use of a 3-dimensional printer. Int J Radiat Oncol Biol Phys (2013) 0.94
Polyostotic fibrous dysplasia mimicking multiple bone metastases in a patient with ductal carcinoma in situ. J Breast Cancer (2014) 0.91
Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients. Strahlenther Onkol (2003) 0.91
Scheduled interval trans-catheter arterial chemoembolization followed by radiation therapy in patients with unresectable hepatocellular carcinoma. J Korean Med Sci (2012) 0.90
Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma. Radiat Oncol J (2015) 0.89
Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06). Clin Breast Cancer (2015) 0.87
The first private-hospital based proton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center. Radiat Oncol J (2015) 0.86
Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer. J Breast Cancer (2013) 0.86
Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes. J Breast Cancer (2016) 0.85
Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014. Cancer Res Treat (2015) 0.82
Predictive factors for Child-Pugh score elevation in hepatocellular carcinoma patients treated with conformal radiation therapy: dose-volume histogram analysis. Tumori (2013) 0.82
Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status and a favorable prognosis in breast cancer. J Breast Cancer (2014) 0.82
Comparison of Her-2, EGFR and cyclin D1 in primary breast cancer and paired metastatic lymph nodes: an immunohistochemical and chromogenic in situ hybridization study. J Korean Med Sci (2008) 0.81
Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC). Cancer Chemother Pharmacol (2010) 0.81
Current practices in cancer pain management in Asia: a survey of patients and physicians across 10 countries. Cancer Med (2015) 0.81
Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07). Clin Breast Cancer (2014) 0.81
Clinical outcomes of local excision following preoperative chemoradiotherapy for locally advanced rectal cancer. Cancer Res Treat (2014) 0.80
Insufficiency fracture after radiation therapy. Radiat Oncol J (2014) 0.80
Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer. Cancer Res Treat (2016) 0.79
Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J (2013) 0.79
Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget (2015) 0.79
A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images. Radiat Oncol J (2016) 0.78
Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases. Radiat Oncol J (2014) 0.78
Prognostic factors in breast cancer with extracranial oligometastases and the appropriate role of radiation therapy. Radiat Oncol J (2015) 0.78
Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population. Cancer Genet (2014) 0.78
Variable uterine uptake of FDG in adenomyosis during concurrent chemoradiation therapy for cervical cancer. Radiat Oncol J (2011) 0.78
The clinical impact of 21-gene recurrence score on treatment decisions for patients with hormone receptor-positive early breast cancer in Korea. Cancer Res Treat (2014) 0.78
Aggressive clinical course of extramammary Paget disease after radiotherapy. Radiat Oncol J (2014) 0.78
Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07). Cancer Res Treat (2016) 0.78
Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress. J Breast Cancer (2017) 0.78
Prophylactic supraclavicular radiotherapy after surgery in high-risk n1 breast cancer. Oncology (2013) 0.77
Exome sequencing in a breast cancer family without BRCA mutation. Radiat Oncol J (2015) 0.77
Limited Supraclavicular Radiation Field in Breast Cancer With ≥ 10 Positive Axillary Lymph Nodes. Clin Breast Cancer (2015) 0.77
Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma. Cancer Res Treat (2014) 0.77
Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA-IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy. J Thorac Oncol (2016) 0.77
Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma. Int J Radiat Oncol Biol Phys (2010) 0.76
Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy. Oncotarget (2016) 0.76
Considerations for radiation therapy in hepatocellular carcinoma: the radiation oncologists' perspective. Dig Dis (2014) 0.76
Invited Commentary on: Can CD44+/CD24- Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy? J Breast Cancer (2011) 0.76
Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis. Yonsei Med J (2015) 0.76
Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series. PLoS One (2016) 0.76
Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells. Ann Surg Treat Res (2014) 0.76
The role of diffusion-weighted magnetic resonance imaging in the treatment response evaluation of hepatocellular carcinoma patients treated with radiation therapy. Int J Radiat Oncol Biol Phys (2014) 0.76
Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade. Genes Chromosomes Cancer (2016) 0.76
Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer. J Cancer Res Clin Oncol (2016) 0.75
Proportion and clinical outcomes of postoperative radiotherapy omission after breast-conserving surgery in women with breast cancer. J Breast Cancer (2015) 0.75
The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC). PLoS One (2016) 0.75
Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer. Radiat Oncol J (2016) 0.75
Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer. Radiat Oncol J (2016) 0.75
Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer. Cancer Res Treat (2016) 0.75
The reasonable timing of the adjuvant radiotherapy in the treatment of uterine carcinosarcoma according to the surgical intent: suggestion based on progression patterns. Radiat Oncol J (2013) 0.75
Can we omit prophylactic inguinal nodal irradiation in anal cancer patients? Radiat Oncol J (2015) 0.75